P891-1729 Screening compound: 1-(3,4-difluorobenzoyl)-4-{3-[3-(propan-2-yl)-1,2,4-oxadiazol-5-yl]pyridin-2-yl}-1,4-diazepane

P891-1729 Screening compound: 1-(3,4-difluorobenzoyl)-4-{3-[3-(propan-2-yl)-1,2,4-oxadiazol-5-yl]pyridin-2-yl}-1,4-diazepane
P891-1729 Screening compound: 1-(3,4-difluorobenzoyl)-4-{3-[3-(propan-2-yl)-1,2,4-oxadiazol-5-yl]pyridin-2-yl}-1,4-diazepane alternative view

Chemical Structure Depiction of ChemDiv screening compound P891-1729
1-(3,4-difluorobenzoyl)-4-{3-[3-(propan-2-yl)-1,2,4-oxadiazol-5-yl]pyridin-2-yl}-1,4-diazepane

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P891-1729

Molecular Formula

C22H23F2N5O2 (C22 H23 F2 N5 O2)

Compound Name

1-(3,4-difluorobenzoyl)-4-{3-[3-(propan-2-yl)-1,2,4-oxadiazol-5-yl]pyridin-2-yl}-1,4-diazepane

IUPAC name

1-(34-difluorobenzoyl)-4-{3-[3-(propan-2-yl)-124-oxadiazol-5-yl]pyridin-2-yl}-14-diazepane

SMILES

CC(C)c1noc(-c2cccnc2N(CCC2)CCN2C(c(cc2)cc(F)c2F)=O)n1

InChI

InChI=1S/C22H23F2N5O2/c1-14(2)19-26-21(31-27-19)16-5-3-8-25-20(16)28-9-4-10-29(12-11-28)22(30)15-6-7-17(23)18(24)13-15/h3,5-8,13-14H,4,9-12H2,1-2H3

InChI Key

XEHIQTPPYQOEMT-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD29027000

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

427.45

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.939

Distribution Coefficient, logD

3.714

Water Solubility, LogSw

-3.88

Polar Surface Area

61.136

Acid Dissociation Constant (pKa)

23.87

Base Dissociation Constant (pKb)

7.23

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

36.40

P891-1729 in Drug Discovery

Included in Screening Libraries

CNS Targets (44014 compounds)

KRAS-Targeted Library (16000 compounds)

Protein-Protein Interaction Library (218420 compounds)

Antibacterial Compounds Library (13827 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Infections
  • Immune system
  • animal
Targets:
  • Kinases
Mechanism of action:
  • PPI modulators
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with P891-1729 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound P891-1729?
Check Price and Availability of P891-1729, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of P891-1729 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for P891-1729
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for P891-1729
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of P891-1729 available by request